JP2007511602A - ５−置換イミダゾール類 - Google Patents

５−置換イミダゾール類 Download PDF

Info

Publication number
JP2007511602A
JP2007511602A JP2006541085A JP2006541085A JP2007511602A JP 2007511602 A JP2007511602 A JP 2007511602A JP 2006541085 A JP2006541085 A JP 2006541085A JP 2006541085 A JP2006541085 A JP 2006541085A JP 2007511602 A JP2007511602 A JP 2007511602A
Authority
JP
Japan
Prior art keywords
disease
compound
formula
disorder
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006541085A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007511602A5 (https=
Inventor
ジェイムズ・エムプフィールド
アイフィーオン・フィリップス
スコット・スロウナー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of JP2007511602A publication Critical patent/JP2007511602A/ja
Publication of JP2007511602A5 publication Critical patent/JP2007511602A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2006541085A 2003-11-19 2004-11-15 ５−置換イミダゾール類 Pending JP2007511602A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303076A SE0303076D0 (sv) 2003-11-19 2003-11-19 5-substituted imidazoles
PCT/SE2004/001659 WO2005049611A1 (en) 2003-11-19 2004-11-15 5-substituted imidazoles

Publications (2)

Publication Number Publication Date
JP2007511602A true JP2007511602A (ja) 2007-05-10
JP2007511602A5 JP2007511602A5 (https=) 2007-11-22

Family

ID=29729100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541085A Pending JP2007511602A (ja) 2003-11-19 2004-11-15 ５−置換イミダゾール類

Country Status (13)

Country Link
US (1) US20080188518A1 (https=)
EP (1) EP1687302A1 (https=)
JP (1) JP2007511602A (https=)
KR (1) KR20060117326A (https=)
CN (1) CN1882583A (https=)
AU (1) AU2004291456A1 (https=)
BR (1) BRPI0416661A (https=)
CA (1) CA2546093A1 (https=)
IL (1) IL175440A0 (https=)
NO (1) NO20062868L (https=)
SE (1) SE0303076D0 (https=)
WO (1) WO2005049611A1 (https=)
ZA (1) ZA200604019B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080103170A1 (en) * 2004-12-16 2008-05-01 Astrazeneca Ab Nicotinic Acetylcholine Receptor Ligands

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01156979A (ja) * 1987-09-10 1989-06-20 Merck Sharp & Dohme Ltd 老人性痴呆症治療用のオキサジアゾリルーアザビシクロヘプタン類
WO2002016355A2 (en) * 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands
JP2002255965A (ja) * 2000-12-29 2002-09-11 Pfizer Prod Inc Ｃｎｓおよび他の疾患のための医薬組成物
WO2003044020A1 (fr) * 2001-11-23 2003-05-30 Sanofi-Synthelabo Derives de 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane, leur preparation et leur application en therapeutique
WO2004043960A1 (en) * 2002-11-11 2004-05-27 Neurosearch A/S 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599916B2 (en) * 2000-08-21 2003-07-29 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
SE0303075D0 (sv) * 2003-11-19 2003-11-19 Astrazeneca Ab 4-substituted imidazoles

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01156979A (ja) * 1987-09-10 1989-06-20 Merck Sharp & Dohme Ltd 老人性痴呆症治療用のオキサジアゾリルーアザビシクロヘプタン類
WO2002016355A2 (en) * 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands
JP2002255965A (ja) * 2000-12-29 2002-09-11 Pfizer Prod Inc Ｃｎｓおよび他の疾患のための医薬組成物
WO2003044020A1 (fr) * 2001-11-23 2003-05-30 Sanofi-Synthelabo Derives de 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane, leur preparation et leur application en therapeutique
WO2004043960A1 (en) * 2002-11-11 2004-05-27 Neurosearch A/S 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof

Also Published As

Publication number Publication date
IL175440A0 (en) 2006-09-05
NO20062868L (no) 2006-08-21
WO2005049611A1 (en) 2005-06-02
ZA200604019B (en) 2007-11-28
CA2546093A1 (en) 2005-06-02
US20080188518A1 (en) 2008-08-07
BRPI0416661A (pt) 2007-01-16
KR20060117326A (ko) 2006-11-16
EP1687302A1 (en) 2006-08-09
CN1882583A (zh) 2006-12-20
SE0303076D0 (sv) 2003-11-19
AU2004291456A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
EP1539764B1 (en) Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists.
RU2233282C2 (ru) Аралкиламины фуропиридинов, способ их получения, фармацевтическая композиция на их основе и промежуточные вещества
JP2006507241A (ja) ニコチン性アセチルコリン作用剤としてのビアリールジアザビシクロアルカンアミド
HUP0301069A2 (hu) Új biaril-karboxamidok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
JP2007532637A (ja) α７ニコチン性アセチルコリン受容体に対する新規な２−（１−アザ−ビシクロ［２．２．２］オクタ−３−イル）−２，３−ジヒドロイソインドール−１−オン／５，６−ジヒドロ−フロ［２，３−ｃ］ピロール−４−オン誘導体リガンド
JP2008524208A (ja) ニコチン性アセチルコリン受容体リガンド
JP2007515479A (ja) ニコチン性アセチルコリンレセプターリガンド
JP2007511603A (ja) ４−置換イミダゾール類
JP2007511602A (ja) ５−置換イミダゾール類
CN100445285C (zh) 烟碱性乙酰胆碱受体配体
JP2007515481A (ja) ニコチン性アセチルコリンレセプターリガンド
JP2007515478A (ja) ニコチン性アセチルコリンレセプターリガンド
MXPA06005415A (en) 5-substituted imidazoles
JP2008524212A (ja) ニコチン性アセチルコリン受容体リガンド
MXPA06005416A (en) 4-substituted imidazoles
JP2007506723A (ja) 非アミド性ノナン

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071001

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071001

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110215

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110823